Recent news on Goserelin Acetate

Biovail Reports Second-Quarter 2006 Financial Results; Company ...  Aug 10, 2006
LP entered into an agreement pursuant to which BPI's specialty sales force began promotional activities for Zoladex(R) 3.6mg (goserelin acetate implant) to ... -Genetic Engineering News



Biovail to Promote AstraZeneca's Zoladex(R) 3.6mg (Goserelin ...  May 2, 2006
Pharmaceuticals LP have entered into an agreement for which BPI's specialty sales force will promote Zoladex(R) 3.6mg (goserelin acetate implant) to ... - Genetic Engineering News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional